Literature DB >> 24861473

Intraoperative ultrasonography is useful in surgical management of neck metastases in differentiated thyroid cancers.

Burak Ertas1, Hakan Kaya, Neslihan Kurtulmus, Abdullah Yakupoglu, Serdar Giray, Omer Faruk Unal, Mete Duren.   

Abstract

Differentiated thyroid carcinomas are the most common malignancies of endocrine organs. Metastases to cervical lymph nodes occur in 20-50% of cases. Recurrence and survival rates are closely related to the type of surgery performed. High-resolution ultrasonography (USG) is a sensitive imaging method used to detect occult lymph node metastases in patients with thyroid cancer. We evaluated how intraoperative USG affected surgical success. This was a retrospective study comparing two groups of patients with thyroid carcinoma who underwent cervical lymph node dissection. A total of 101 patients (33 males and 68 females) were included. Group 1 included 53 patients who underwent surgery with intraoperative USG guidance. Group 2 included 48 patients who underwent surgery without the use of USG. All patients were followed up (mean 23 months; range 5-44 months) with thyroglobulin measurements and USG evaluations. Group 1 (intraoperative USG) had a residual/recurrent tumor rate of 1.9% (1/53 patients). Group 2 had a residual/recurrent tumor rate of 12.5% (6/48 patients). A statistically significant difference appeared between the residual/recurrent tumor rates in Groups 1 and 2 (p<0.05). In addition to its classical use in diagnosis and follow-up, intraoperative use of high-resolution USG can improve surgical success and may decrease the number of residual/recurrent tumors encountered during follow-up.

Entities:  

Mesh:

Year:  2014        PMID: 24861473     DOI: 10.1007/s12020-014-0287-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  31 in total

1.  Intraoperative ultrasonography improves identification of recurrent thyroid cancer.

Authors:  John K Karwowski; R Brooke Jeffrey; I Ross McDougall; Ronald J Weigel
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

Review 2.  Level V in therapeutic neck dissections for papillary thyroid carcinoma.

Authors:  Avi Khafif; Jesus E Medina; K Thomas Robbins; Carl E Silver; Randal S Weber; Alessandra Rinaldo; Randall P Owen; Ashok R Shaha; Alfio Ferlito
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

3.  In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.

Authors:  Mauricio A Moreno; Beth S Edeiken-Monroe; Eric R Siegel; Steven I Sherman; Gary L Clayman
Journal:  Thyroid       Date:  2012-01-26       Impact factor: 6.568

4.  Usefulness of thyroglobulin measurement in needle washouts of fine-needle aspiration biopsy for the diagnosis of cervical lymph node metastases from papillary thyroid cancer before thyroidectomy.

Authors:  Dae-Weung Kim; Se Jeong Jeon; Chang Guhn Kim
Journal:  Endocrine       Date:  2012-02-18       Impact factor: 3.633

Review 5.  Advances in ultrasound for the diagnosis and management of thyroid cancer.

Authors:  Jennifer A Sipos
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

6.  Does failure to perform prophylactic level VI node dissection leave persistent disease detectable by ultrasonography in patients with low-risk papillary carcinoma of the thyroid?

Authors:  Jack M Monchik; Caroline J Simon; Diana L Caragacianu; Alan A Thomay; Vicki Tsai; Jonah Cohen; Peter J Mazzaglia
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

7.  Staging in thyroid carcinoma.

Authors:  B Cady
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

8.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

9.  Detection and surgical treatment of cervical lymph nodes in differentiated thyroid cancer.

Authors:  John C Watkinson; Jayne A Franklyn; Julie F C Olliff
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

10.  Risk factor analysis in differentiated thyroid cancer.

Authors:  B Cady; C E Sedgwick; W A Meissner; M S Wool; F A Salzman; J Werber
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

View more
  1 in total

1.  Association between contrast-enhanced ultrasonography and histopathological findings of the metastatic lymph nodes of patients with head and neck cancer: A preliminary study.

Authors:  Shin-Ichi Oikawa; Kiyoto Shiga; Daisuke Saito; Katsunori Katagiri; Aya Ikeda; Kodai Tuchida; Jun Miyaguchi; Kazuyuki Ishida; Tamotsu Sugai
Journal:  Oncol Lett       Date:  2018-01-22       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.